HBLAX | UGTAX | HBLAX / UGTAX | |
Total Expense Ratio | 0.89 | 0.83 | 107% |
Annual Report Gross Expense Ratio | 0.89 | 0.93 | 96% |
Fund Existence | 19 years | 5 years | - |
Gain YTD | 1.523 | -2.392 | -64% |
Front Load | 6% | 2% | 244% |
Min. Initial Investment | 2000 | 2500 | 80% |
Min. Initial Investment IRA | 2000 | N/A | - |
Net Assets | 11.6B | 815M | 1,423% |
Annual Yield % from dividends | 3.41 | 1.55 | 220% |
Returns for 1 year | 2.22 | 4.95 | 45% |
Returns for 3 years | 8.90 | 24.29 | 37% |
Returns for 5 years | 18.01 | N/A | - |
Returns for 10 years | 32.53 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MCDCX | 19.30 | 0.06 | +0.31% |
BlackRock Emerging Mkts Inv C | |||
SPUSX | 13.95 | -0.01 | -0.07% |
Symmetry Panoramic US Equity I | |||
CFNFX | 80.17 | -0.13 | -0.16% |
American Funds Fundamental Invs 529F1 | |||
LVOCX | 13.37 | -0.04 | -0.30% |
Lord Abbett Value Opportunities C | |||
HBGHX | 13.34 | -0.16 | -1.19% |
Hartford Healthcare HLS IB |